Xeloda (capecitabine)
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Xeloda (capecitabine), covering 2011-11-09 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC) [Phase 1, Phase 2]